SCN3A — NaV1.3
SCN3A (NaV1.3) is a lever-L1 non-opioid analgesic target. Its promoter reads γ = 1.2645, placing it on the firing-threshold scale at |hsp| = 0.547301; the intervention direction is to reduce inward Na⁺. The read is reproducible [V]; the clinical magnitude is open [O].
SCN3A is read from its human promoter by the same deterministic engine used across the map (nearest-neighbour stacking energy → γ = 1.2645; R19 scale → |hsp| = 0.547301). The read places the gene in lever L1; its selectivity is cited Layer-2 biology, and every clinical magnitude (potency, dose, efficacy, safety) is graded [O].
The read
SCN3A — NaV1.3 sits in the threshold map at γ = 1.2645, |hsp| = 0.547301 (barrier 0.39974). It belongs to lever L1; the intervention direction is to reduce inward Na⁺ (Na_V1.3, re-expressed/up-regulated after nerve injury).
selectivity (cited) developmentally regulated; up-regulated in injured DRG/CNS
burden Tier-1 neuropathic
Grades
- read [V] reproducible promoter-switch-threshold read
- order [F] forced by reads
- lever [F] structural lever + direction (anchored to cited agents)
- mechanism [F] structural: peripheral current block raises the firing threshold (anchored to cited agents)
- clinical magnitude [O] OPEN — not a voltage, potency, dose, selectivity-in-vivo, or effect
Firewall. γ here is a read of promoter switch-threshold structure only — never this channel's activation voltage, a candidate's potency, a dosing quantity, an in-vivo selectivity, or a clinical effect. Those magnitudes are [O] open.
Source
Hains 2003 J Neurosci 23:8881 (Na_V1.3 up-regulation after injury) · reproduce the read (engine)
See also: its lever · prioritisation · grading.